Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
April 30, 2025
Completed Patient Enrollment for an NCE Clinical Program
Driving Innovation: Completed Patient Enrollment for an NCE Clinical Program
Type of study: Phase 1
Indication: Age-Related Wet Macular Degeneration
Scope: End-to-end clinical trial management
Country of trial execution: USA
CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION
Manoj Vyas
Dr. Sandeep Singh
Jaimeen Vanparia
Sanjeev Ganatra
Mark Kirschbaum
Nikhil Gandhi
Harakh Shah, PMP®
Tapan Shah
Kinnari Gandhi RQAP-GCP
Dr. Praveen Choudhary
Nikunj Patel
Ankit Parikh
Ajit Upadhyaya
Ankit Pandav
Devang Pandya
Jay Vyas
Udayan Vyas